New study eliciting a positive reaction from the scientific community:
“... rare but recurring RBD-specific antibodies with potent antiviral activity were found in all individuals tested, suggesting that a vaccine designed to elicit such antibodies could be broadly effective.”
www.biorxiv.org/content/10.1101/2020.05.13.092619v1
According to lead virologist, Paul Bieniasz:
“A mixture of good news and less good news:
Less good news: Many individuals who had mild #COVID19 mount weak neutralizing antibody response
Good news: looks like most CAN mount a potent neutralizing response. A good vaccine MIGHT give better protection than natural infection.”
Out with ‘herd immunity’ by the sounds of things...